AtonRa Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $576K | Sell |
58,722
-6,360
| -10% | -$62.4K | 1.15% | 26 |
|
|
2023
Q3 | $543K | Buy |
65,082
+2,504
| +4% | +$20.9K | 1.14% | 22 |
|
|
2023
Q2 | $832K | Sell |
62,578
-13,853
| -18% | -$184K | 1.29% | 20 |
|
|
2023
Q1 | $885K | Sell |
76,431
-10,748
| -12% | -$124K | 1.29% | 14 |
|
|
2022
Q4 | $713K | Sell |
87,179
-42,862
| -33% | -$351K | 0.91% | 45 |
|
|
2022
Q3 | $755K | Sell |
130,041
-13,903
| -10% | -$80.7K | 0.74% | 60 |
|
|
2022
Q2 | $636K | Buy |
143,944
+84,740
| +143% | +$374K | 0.58% | 78 |
|
|
2022
Q1 | $539K | Sell |
59,204
-9,891
| -14% | -$90K | 0.29% | 105 |
|
|
2021
Q4 | $1.41M | Sell |
69,095
-25,205
| -27% | -$516K | 0.49% | 72 |
|
|
2021
Q3 | $2.41M | Buy |
94,300
+36,576
| +63% | +$934K | 0.81% | 54 |
|
|
2021
Q2 | $2.02M | Buy |
57,724
+30,943
| +116% | +$1.08M | 0.74% | 62 |
|
|
2021
Q1 | $892K | Buy |
+26,781
| New | +$892K | 0.4% | 97 |
|